ES2564138T3 - Ensayo para Hemaglutinina del virus de la influenza - Google Patents

Ensayo para Hemaglutinina del virus de la influenza

Info

Publication number
ES2564138T3
ES2564138T3 ES12818607.9T ES12818607T ES2564138T3 ES 2564138 T3 ES2564138 T3 ES 2564138T3 ES 12818607 T ES12818607 T ES 12818607T ES 2564138 T3 ES2564138 T3 ES 2564138T3
Authority
ES
Spain
Prior art keywords
influenza virus
hemagglutinin
virus hemagglutinin
vaccine
hemagglutinin assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12818607.9T
Other languages
English (en)
Inventor
Philip Dormitzer
William Andrews
Paola Rinella
Domenico ROSA
Giuseppe Palladino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2564138T3 publication Critical patent/ES2564138T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus

Abstract

Un método para analizar una vacuna conformado de los siguientes pasos: (a) detectar la hemaglutinina del virus de la influenza en la vacuna, o una de sus muestras, con los siguientes pasos: (i) contactar a la muestra con una lectina que es inmovilizada en un soporte sólido, para suministrar a la hemaglutinina capturada; y (ii) detectar a la hemaglutinina capturada por medio de un inmunoensayo; y (b) utilizar los resultados del paso (a) para calcular la concentración de hemaglutinina en la vacuna.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16

Claims (1)

  1. imagen1
    imagen2
ES12818607.9T 2011-12-12 2012-12-12 Ensayo para Hemaglutinina del virus de la influenza Active ES2564138T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161569597P 2011-12-12 2011-12-12
US201161569597P 2011-12-12
PCT/IB2012/057235 WO2013088367A1 (en) 2011-12-12 2012-12-12 Assay for influenza virus hemagglutinins

Publications (1)

Publication Number Publication Date
ES2564138T3 true ES2564138T3 (es) 2016-03-18

Family

ID=47603885

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12818607.9T Active ES2564138T3 (es) 2011-12-12 2012-12-12 Ensayo para Hemaglutinina del virus de la influenza

Country Status (7)

Country Link
US (1) US20140335507A1 (es)
EP (2) EP3023790A1 (es)
JP (1) JP2016539314A (es)
CA (1) CA2858794A1 (es)
ES (1) ES2564138T3 (es)
HK (1) HK1202924A1 (es)
WO (1) WO2013088367A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102094727B1 (ko) * 2012-10-05 2020-03-30 덴카 세이켄 가부시키가이샤 인플루엔자 바이러스의 헤마글루티닌 측정 방법
US10732180B2 (en) 2014-06-04 2020-08-04 Indevr, Inc. Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins
JP2016146809A (ja) * 2015-02-13 2016-08-18 国立大学法人広島大学 ウイルス分離デバイス
JP2016147839A (ja) * 2015-02-13 2016-08-18 国立大学法人広島大学 タンパク質分離デバイス、タンパク質を分離する方法、および、高マンノース型糖鎖の構造を決定する方法
US11519876B2 (en) 2019-10-07 2022-12-06 National University Corporation Shizuoka University Electrode for electrochemical measurement
US20220299512A1 (en) * 2020-04-06 2022-09-22 Medicortex Finland Oy Method for determining coronavirus and kit for the same
US20240019438A1 (en) 2020-12-31 2024-01-18 Teledyne Flir Detection, Inc. Assays for rapid detection of airborne viruses including influenza and coronaviruses

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
CN1149888A (zh) 1994-01-11 1997-05-14 福拉姆斯大学生物技术研究所 流感疫苗
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
AU7126998A (en) 1997-04-16 1998-11-11 Connaught Laboratories Inc. Anti-influenza compositions supplemented with neuraminidase
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
EP1260581B1 (en) 2000-03-03 2010-07-07 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
EP1624785B1 (en) * 2003-01-17 2013-07-17 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
ES2313310T3 (es) 2004-03-17 2009-03-01 Crucell Holland B.V. Nuevo ensayo para la separacion y cuantificacion de antigenos hemaglutinina.
WO2005097181A1 (en) 2004-04-05 2005-10-20 Pfizer Products Inc. Microfluidized oil-in-water emulsions and vaccine compositions
KR20070060049A (ko) 2004-05-20 2007-06-12 아이디 바이오메디칼 코포레이션 인플루엔자 백신의 제조방법
ES2432655T3 (es) * 2004-09-09 2013-12-04 Novartis Vaccines And Diagnostics Gmbh Reducción de riesgos iatrogénicos potenciales asociados con antígenos de vacunas
DK2368975T3 (en) 2004-12-23 2015-01-05 Medimmune Llc Non-tumorigenic MDCK cell line for the propagation of viruses
JP2006265197A (ja) * 2005-03-25 2006-10-05 Daikin Ind Ltd 抗原性人工ポリペプチド
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
ES2399350T3 (es) 2005-11-04 2013-03-27 Novartis Vaccines And Diagnostics S.R.L. ELISA rápido
BRPI0707300B8 (pt) * 2006-01-27 2021-05-25 Novartis Ag vacina contra vírion influenza dividido ou antígeno de superfície purificado e método para a preparação de uma composição imunogênica
WO2008001221A2 (en) 2006-06-21 2008-01-03 Novartis Ag Concurrent delivery device for multiple vaccines
CA3016948A1 (en) 2006-09-11 2008-03-20 Seqirus UK Limited Making influenza virus vaccines without using eggs
CN101522218B (zh) 2006-10-12 2012-09-26 葛兰素史密丝克莱恩生物有限公司 包含水包油乳液佐剂的疫苗
JP5187883B2 (ja) * 2007-07-18 2013-04-24 独立行政法人科学技術振興機構 抗原ペプチドおよびその利用
NZ590891A (en) * 2008-07-25 2013-03-28 Inst Research In Biomedicine Neutralizing anti-influenza a virus antibodies and uses thereof
WO2010136896A1 (en) 2009-05-29 2010-12-02 Novartis Ag Assays for influenza virus hemagglutinins

Also Published As

Publication number Publication date
WO2013088367A1 (en) 2013-06-20
HK1202924A1 (zh) 2015-10-09
US20140335507A1 (en) 2014-11-13
EP2791680A1 (en) 2014-10-22
JP2016539314A (ja) 2016-12-15
CA2858794A1 (en) 2013-06-20
EP3023790A1 (en) 2016-05-25
EP2791680B1 (en) 2015-12-09

Similar Documents

Publication Publication Date Title
ES2564138T3 (es) Ensayo para Hemaglutinina del virus de la influenza
ES2554993T3 (es) Sistema de análisis para el análisis de muestras biológicas, métodos y producto de programa informático
CL2017001940A1 (es) Dispositivo de medición de la calidad del suelo
BR112015025762A2 (pt) método e dispositivo para determinar a sequência de bases de nucleotídeos em um analito de polinucleotídeos
BR112016008970A2 (pt) Método de ativação ex vivo e para avaliar ativação plasmática em um indivíduo, ensaio ex vivo para determinar atividade de calicreína plasmática em uma amostra
BR112015023742A2 (pt) Aparelho, método e sistema para montar um objeto em uma superfície de suporte
BR112015017473A2 (pt) método para detectar um agente patogênico em uma amostra, e, kit de análise de agente patogênico
BR112017021686A2 (pt) método para detectar uma ou várias carbapenemases, dispositivo para detectar imunocromatográfico e uso do dispositivo para detectar imunocromatográfico
BR112015025407A2 (pt) método e dispositivo para testar um transformador
CO2019012771A2 (es) Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos
WO2014015194A3 (en) Methods for detecting and measuring aggregation
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
BR112018006635A2 (pt) métodos para diagnosticar doenças infecciosas usando meio de adsorção
PE20141450A1 (es) Ensayo de lisiloxidasa-homologo 2 y metodos de uso del mismo
CL2016001588A1 (es) Método y aparato de identificación de gemas al comparar el espectrograma raman de la muestra con una biblioteca referencial de espectrogramas raman para gemas a fin de identificar la muestra.
AR102517A1 (es) Ensayos para detectar subgrupos inmunes de células t y sus métodos de uso
BR112014001389A2 (pt) método para o reparo de um arquivo de sistema e aparelho para reparar um arquivo de sistema
EP4220158A3 (en) Urine specimen analysis device and urine specimen analysis method
BR102016030970A8 (pt) Aparelho de processamento de matriz
BR112018016971A2 (pt) aparelho, sistema e método de inspeção de formato de eixo de manivela
BR112014031182A2 (pt) método para testar uma formação, sistema para testar a pressão de uma formação e meio de armazenamento legível por computador
EA201300009A1 (ru) Точные интегрированные электродные чипы для микроанализа и способ использования в системах с возбуждением электрохемилюминесценции горячими электронами
CL2016001073A1 (es) Ácidos nucleicos y métodos para detectar microorganismos patógenos y benéficos.
AR059361A1 (es) Dispositivo y metodos para detectar y cuantificar uno o mas agentes objetivos
BR112014032974A2 (pt) método para detecção, identificação e/ou quantificação de um ou mais carboidratos, uso de um oligotiofeno conjugado luminescente, e composto